Insiders Cyclerion Therapeutics, Inc.

Equities

CYCN

US23255M2044

Market Closed - Nasdaq Other stock markets 21:30:00 10/05/2024 BST			5-day change	1st Jan Change
3.15 ^USD	+5.00%		+10.92%	-5.97%

05-07	Cyclerion Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-05	Cyclerion Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cyclerion Therapeutics, Inc. Appoints Regina Graul as President	12-04	CI
Cyclerion Therapeutics, Inc. Announces Board of Directors Appointments	11-30	CI
Cyclerion Therapeutics, Inc. Announces Resignation of Ole Isacson as Director	11-24	CI
Cyclerion Therapeutics, Inc. Announces Anjeza Gjino Resigns as Chief Financial Officer	23/10/23	CI
Cyclerion Therapeutics, Inc. Announces Resignation of Cheryl Gault as Chief Operating Officer	27/06/23	CI
Cyclerion Therapeutics to Sell Zagociguat, CY3018 Assets to New Private Company	12/05/23	MT
Cyclerion Therapeutics, Inc. Announces Resignation of Andreas Busch as Chief Scientific Officer	30/09/22	CI
Cyclerion Therapeutics, Inc. - Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics' Board of Directors	27/07/22	AQ
Cyclerion Therapeutics : Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors - Form 8-K	26/07/22	PU
Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors	26/07/22	GL
Steven E. Hyman, M.D., Appointed to Cyclerion Therapeutics’ Board of Directors	26/07/22	GL
Cyclerion Therapeutics, Inc. Announces Appointment of Steven E. Hyman, M.D., to its Board of Directors	26/07/22	CI
Cyclerion Therapeutics, Inc. Announces Resignation of Kevin B. Churchwell from the Board	19/08/21	CI
Cyclerion Therapeutics Appoints Errol De Souza, Ph.D., to Board of Directors	26/04/21	CI
Cyclerion Therapeutics, Inc. Announces Departure of Christopher Wright as Chief Medical Officer	18/03/21	CI
Cyclerion Therapeutics Announces Clinical and Scientific Advisory Boards	25/01/21	CI
Cyclerion Therapeutics, Inc. Announces Management Changes	21/12/20	CI
Cyclerion Announces the Appointment of Andreas Busch as Chief Innovation Officer	09/04/19	CI
Cyclerion Therapeutics, Inc. Announces Executive Changes	02/04/19	CI
Cyclerion Therapeutics, Inc. Appoints Marsha Fanucci to the Board	19/03/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cyclerion Therapeutics, Inc.

Equities

CYCN

US23255M2044

Insiders

Filters